Innovent Biologics, Inc. (IVBXF)
13.30
-0.31
(-2.28%)
USD |
OTCM |
Aug 25, 16:00
Innovent Biologics Market Cap : 23.07B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 23.07B |
| August 24, 2026 | 23.61B |
| August 21, 2026 | 20.48B |
| August 20, 2026 | 21.52B |
| August 19, 2026 | 21.52B |
| August 18, 2026 | 21.52B |
| August 17, 2026 | 21.46B |
| August 14, 2026 | 21.46B |
| August 13, 2026 | 21.46B |
| August 12, 2026 | 21.46B |
| August 11, 2026 | 21.46B |
| August 10, 2026 | 21.51B |
| August 07, 2026 | 21.44B |
| August 06, 2026 | 21.30B |
| August 05, 2026 | 19.63B |
| August 04, 2026 | 18.53B |
| August 03, 2026 | 18.53B |
| July 31, 2026 | 18.62B |
| July 30, 2026 | 21.07B |
| July 29, 2026 | 21.67B |
| July 28, 2026 | 21.37B |
| July 27, 2026 | 17.90B |
| July 24, 2026 | 18.79B |
| July 23, 2026 | 22.20B |
| July 22, 2026 | 22.20B |
| Date | Value |
|---|---|
| July 21, 2026 | 18.84B |
| July 20, 2026 | 22.49B |
| July 17, 2026 | 20.82B |
| July 16, 2026 | 22.20B |
| July 15, 2026 | 20.00B |
| July 14, 2026 | 18.92B |
| July 13, 2026 | 18.90B |
| July 10, 2026 | 19.76B |
| July 09, 2026 | 19.68B |
| July 08, 2026 | 19.60B |
| July 07, 2026 | 17.61B |
| July 06, 2026 | 20.25B |
| July 02, 2026 | 19.18B |
| July 01, 2026 | 19.18B |
| June 30, 2026 | 19.13B |
| June 29, 2026 | 17.82B |
| June 26, 2026 | 17.32B |
| June 25, 2026 | 16.50B |
| June 24, 2026 | 17.85B |
| June 23, 2026 | 17.02B |
| June 22, 2026 | 17.02B |
| June 18, 2026 | 17.28B |
| June 17, 2026 | 16.58B |
| June 16, 2026 | 17.44B |
| June 15, 2026 | 16.68B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascletis Pharma, Inc. | 1.286B |
| CStone Pharmaceuticals Co. Ltd. | 1.032B |
| RemeGen Co., Ltd. | 5.792B |
| InnoCare Pharma Ltd. | 2.735B |
| Adagene, Inc. | 256.49M |
Market Cap Related Metrics
| PE Ratio | 133.40 |
| PS Ratio | 10.45 |
| Price | 13.30 |
| Earnings Yield | 0.75% |
| Operating PE Ratio | 61.85 |
| Normalized PE Ratio | 130.65 |